Background: Direct coronary stenting is a validated therapeutic option for coronary lesions. We studied the feasibility of direct deployment with a bioresorbable vascular scaffold (BVS) in acute coronary syndrome (ACS).
Methods: Demographic, procedural, and survival data were obtained for patients who had direct scaffold deployment with BVS from 1 May 2013 to 1 April 2014.
Results: We performed a retrospective review of nine patients which included eight patients having ST-elevation myocardial infarction. There were no cases of worsening coronary flow, scaffold thrombosis, target lesion revascularization or death up to 30 days post intervention.
Conclusion: Direct BVS deployment in ACS appears safe and feasible.
Keywords: Bioresorbable vascular scaffold; Direct coronary stenting; Myocardial infarction.
Copyright © 2015 Elsevier Inc. All rights reserved.